Prognosis and predictive factors for Patients with COVID-19 combined with Interstitial Lung Disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300074855

Enrollment

Unknown

Registered

2023-08-17

Start date

2023-08-30

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung disease

Interventions

Group of fILD patients:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:(1)fILDs confirmed by multidisciplinary discussion. (2) Epidemiological history, corresponding clinical symptoms, and positive SARS-CoV-2 nasal/pharyngeal swab PCR or antigen test.

Exclusion criteria

Exclusion criteria: Exclusion criteria:(1)patients younger than 18 years old(2)fibrosis on HRCT < 10%(3)heart, liver and renal decompasation(4)withdrew from the study(5)lost to follow-up.

Design outcomes

Primary

Measure	Time frame
lung function;HRCT;death;	—

Countries

China

Contacts

Public ContactQiao Ye

Beijing Chaoyang Hospital

yeqiao_chaoyang@sina.com+86 134 3652 0511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026